Selection of ciprofloxacin resistance in Escherichia coli in an in vitro kinetic model: relation between drug exposure and mutant prevention concentration

The Journal of Antimicrobial Chemotherapy
Sara K OlofssonOtto Cars

Abstract

To evaluate the mutant prevention concentrations (MPCs) of ciprofloxacin for two susceptible and one first-step gyrA resistant mutant Escherichia coli strains in an in vitro kinetic model and to identify the pharmacodynamic index that best predicts prevention of resistance emergence. An in vitro kinetic model was used to measure MPC with static antibiotic concentrations and to test different dosing profiles to study pharmacokinetics/pharmacodynamics indices important to prevent the growth of resistant mutants. In one set of kinetic experiments the starting concentration was equal to the MPC and the T > MPC was varied before antibiotic dilution was begun. In a second set of kinetic experiments C(max) was varied and dilution of the antibiotic was started at time zero. From the static experiments we calculated MPC values of 0.128 mg/L for both the susceptible strains (16x MIC) and 0.188 mg/L (4x MIC) for the first-step resistant (gyrA) strain. The kinetic experiments showed that the T > MPC needed to prevent the growth of resistant bacteria was shorter with an increased C(max). When resistance was selected, several subpopulations with different levels of susceptibility to ciprofloxacin emerged. Neither T > MPC nor C(max) proved to...Continue Reading

Citations

Feb 6, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Karl Drlica, Xilin Zhao
Aug 19, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Sara K Olofsson, Otto Cars
Jun 12, 2008·The Journal of Antimicrobial Chemotherapy·Xilin Zhao, Karl Drlica
May 23, 2009·The Journal of Antimicrobial Chemotherapy·George P Allen, Cynthia D Hankins
Sep 29, 2011·The Journal of Antimicrobial Chemotherapy·H-G Wetzstein, W Hallenbach
Jul 4, 2008·Critical Care Medicine·Jason A RobertsJeffrey Lipman
May 15, 2013·Antimicrobial Agents and Chemotherapy·Orsolya MéhiCsaba Pál
Nov 19, 2013·PloS One·Markus ArnoldiniFrederik Hammes
Dec 19, 2013·Journal of Avian Medicine and Surgery·Samanta WaxmanCasilda Rodriguez
Jul 27, 2014·Molecular Biology and Evolution·Orsolya MéhiCsaba Pál
May 21, 2014·Proceedings of the National Academy of Sciences of the United States of America·Peter Ankomah, Bruce R Levin
Mar 19, 2016·BioMed Research International·Ijaz AhmadZonghui Yuan
Jan 19, 2016·Frontiers in Veterinary Science·KaNa SangZongHui Yuan
Feb 16, 2008·International Journal of Antimicrobial Agents·Joseph M Blondeau, Glenn Tillotson
Sep 21, 2006·The Veterinary Clinics of North America. Small Animal Practice·Dawn Merton Boothe
Jul 23, 2008·Risk Analysis : an Official Publication of the Society for Risk Analysis·H Scott Hurd, Sasidhar Malladi
Jul 5, 2011·FEMS Microbiology Reviews·Rafael Cantón, María-Isabel Morosini
Jul 7, 2014·The Veterinary Journal·Jane E Sykes, Joseph M Blondeau
Feb 15, 2015·Trends in Microbiology·Troy DayAndrew F Read
Apr 29, 2014·The Lancet Infectious Diseases·Jason A RobertsUNKNOWN International Society of Anti-Infective Pharmacology and the Pharmacokinetics and Pharmacodynamics Study Group of the Europe
Jun 30, 2016·Cellular Microbiology·Yanan ZhaoDavid S Perlin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.